Efficacy of systematic catheter locks solution of taurolidine/heparin versus taurolidine/urokinase in end-stage renal insufficiency stage 5D

Nefrologia (Engl Ed). 2022 Sep-Oct;42(5):611-613. doi: 10.1016/j.nefroe.2021.02.013. Epub 2023 Jan 18.
No abstract available

Publication types

  • Letter

MeSH terms

  • Catheters
  • Heparin* / adverse effects
  • Humans
  • Kidney Failure, Chronic* / complications
  • Kidney Failure, Chronic* / therapy
  • Urokinase-Type Plasminogen Activator

Substances

  • Heparin
  • Urokinase-Type Plasminogen Activator
  • taurolidine